Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rivaroxaban
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Anticoagulants
- ATC
- B01AF
- Strength
- 20 mg
- Dosage form
- Tablet
- Pack
- 14's
- Registration no.
- 110661
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 11,907.93 to 12,496.18 (+4.9%) between 5 Sep 2025 and 20 Aug 2026 · 2 official price records · pack 14's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Raban 20 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/raban-20-mg-110661-14s-mass-pharma-pvt-ltd/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 12,496.18 | 2026-08-20 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 11,907.93 | 2025-09-05 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 110661Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
